Top Markets
#1 Akedo Akedo +59.32%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.39%
#4 Velvet Velvet +43.06%
#5 Black Phoenix Black Phoenix +34.58%
#6 τemplar τemplar +22.94%
#7 Cap Cap +19.28%
#8 Ribbita by Virtuals Ribbita by Virtuals +17.53%
#9 Cross Cross +17.30%
#10 Bitway Bitway +15.59%
Coin of the day
Akedo Akedo
設定
言語
日本
通貨
USD
テーマ
Nutroganics, Inc. Nutroganics, Inc.

Nutroganics, Inc.

NUTTQ
株式のランク #38311
Nutroganics, Inc.'s primary business strategy involved acquiring and overseeing... Nutroganics, Inc.'s primary business strategy involved acquiring and overseeing profitable companies within the healthy lifestyle industry, focusing heavily on nutritional supplements and the natural and organic food markets. One of its key operational entities was Silverbow Honey Company, a subsidiary that handled the production, packaging, and sale of various honey products. These goods were supplied to food manufacturers and prominent national grocery chains, marketed under both the Silverbow brand and as private label offerings. The company was based in Bethesda, Maryland. However, a significant development occurred on October 14, 2016, when Nutroganics, Inc. and its affiliated organizations filed a voluntary petition for Chapter 7 liquidation with the US Bankruptcy Court for the District of Delaware.
株価
$0.00001
最終同期: 2025-05-07
時価総額
$1.07M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Nutroganics, Inc. (NUTTQ)

カテゴリー

Healthcare
Nutroganics, Inc.（NUTTQ）の株価履歴
終値の最高値: $0.00 （2025-05-01）

終値の最安値: $0.00 （2024-10-01）
Nutroganics, Inc. の株価履歴（2024 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2025 0.00%
2024 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $58.56 60.44%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 $49.19 73.40%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 $185.04 42.71%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 $62.27 4.40%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $114.37 58.84%
US